Göran Stiernstedt: “We are the world’s worst at continuity”

Failed investments in primary care, an unreasonable system with online doctors and a public failure at coordinating the healthcare IT system. Göran Stiernstedt ...

Delivering drugs with small devices

There are many challenges to overcome when delivering a drug orally. Getting the drug to survive the low pH of the ventricle and being released at the correct s...

Hello Angelica Loskog!

Life Science Sweden would like to know more about Angelica Loskog and interviews her about her life as a researcher.

Pfizer lays a chunky bid on Wyeth

The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...

EU grants project on toxicity of nanomaterials

A multinational research project has have been awarded EUR 3 358 500 from the European Commission to study the hazardous effects of engineered nanomaterials on ...

The route to vaccines for everyone: “We did not just sit around and wait”

The pandemic was in full swing, and no one knew when or even if a vaccine would come. At that point, the Swedish Minister of Social Affairs called with a propos...

Anna Törner: You won’t find this many Concorde projects anywhere else

"Suddenly Concorde projects seem reasonable in life science because it´s about life and death", writes Anna Törner in a column.

Nexium-mål läggs ned

Domstol i Boston lägger ner konkurrensmål där Astrazeneca anklagas för att ha fördröjt generikalanseringar

Anna Törner: Kalashnikovs in a new guise

Thanks to resisting European regulatory authorities, Europe has been spared the opioid epidemic. In the 1960s, the situation was the opposite as the American ph...

Konsolidering i medtech-branschen

Nya hälsovårdsprogrammet Medicare sätter press på utbuden hos medicinteknikbolagen i USA. Nu planerar två jättar att slå sina påsar ihop.

Shire förbereder för nytt bud

Läkemedelsbolaget kallade till investerarträff under gårdagen i händelse av att Abbvie höjer sitt senaste bud.

Event: Drug Development – Serendipity or Science

Drug development is a challenging journey, we will discuss questions you may not even consider asking. SDS and Medicon Village welcome you to an engaging afternoon.

Combining two drug delivery strategies to improve bioavailability

Danish researchers hope to increase the bioavailability of low solubility drugs.

Astrazeneca får backning på cancerkandidat

FDA:s rådgivande kommitté menar att det behövs mer data kring läkemedelskandidaten olaparid mot äggstockscancer.

Har du övervägt att renovera dina ventiler?

Liksom alla andra mekaniska delar bör ventiler servas regelbundet för att bibehålla sin optimala prestanda och produktivitet.

Bring talent to those in need

Ho ho ho, Christmas time is here again. So get busy decking the halls, perhaps not with assorted greenery, but with something of a more lasting value.

Topp 10 mest sålda läkemedel

Top tio-listan av de läkemedel som sålt bäst på den amerikanska marknaden

Biotech goes white and bright

White biotech could become Denmark's next blossoming business area.

IRW Consulting is seeking Clinical Research Associates (CRAs) on positions located in Stockholm

He is heading a new company for the development of Coegin’s cancer drug

The biotechnology company Coegin Pharma places the development of its drug candidate AVX420 in a newly formed company, Avexxin Oncology, based in Norway, and Jo...

Novavax is developing a vaccine candidate against Covid-19 and seasonal flu

A combined vaccine against both Covid-19 and seasonal flu is showing promising results in studies, according to the American drug developer Novavax. The adjuvan...

Sekvenseringsjätten BGI satsar på molnet

Analys och datalagring av DNA-sekvenser tar stora datorresurser i anspråk.

Pfizer kan ta upp jakten

Om Astrazeneca är villigt kan nya samtal om uppköp inledas redan nästa vecka.

A growing industry in Denmark: “One new life science company a week”

The life science sector in eastern Denmark continues to grow in the number of employees, as well as the number of companies. An emerging problem is the shortage of labour, a new...